Wynnstay Group PLC
LSE:WYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Wynnstay Group PLC
LSE:WYN
|
UK |
|
R E A Holdings PLC
LSE:RE
|
UK |
|
A
|
Aarti Pharmalabs Ltd
NSE:AARTIPHARM
|
IN |
Balance Sheet
Balance Sheet Decomposition
Wynnstay Group PLC
Wynnstay Group PLC
Balance Sheet
Wynnstay Group PLC
| Oct-2002 | Oct-2003 | Oct-2004 | Oct-2005 | Oct-2006 | Oct-2007 | Oct-2008 | Oct-2009 | Oct-2010 | Oct-2011 | Oct-2012 | Oct-2013 | Oct-2014 | Oct-2015 | Oct-2016 | Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | Oct-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
7
|
9
|
10
|
10
|
9
|
7
|
11
|
20
|
20
|
31
|
31
|
38
|
|
| Cash Equivalents |
1
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
7
|
9
|
10
|
10
|
9
|
7
|
11
|
20
|
20
|
31
|
31
|
38
|
|
| Short-Term Investments |
0
|
0
|
2
|
1
|
3
|
5
|
4
|
3
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
3
|
1
|
1
|
1
|
|
| Total Receivables |
12
|
16
|
16
|
18
|
20
|
25
|
31
|
26
|
36
|
46
|
47
|
51
|
49
|
49
|
50
|
63
|
71
|
64
|
56
|
73
|
95
|
79
|
69
|
|
| Accounts Receivables |
11
|
14
|
15
|
17
|
19
|
24
|
30
|
25
|
34
|
43
|
45
|
49
|
46
|
46
|
47
|
61
|
67
|
62
|
53
|
70
|
95
|
78
|
68
|
|
| Other Receivables |
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Inventory |
5
|
7
|
8
|
8
|
10
|
9
|
15
|
13
|
18
|
24
|
27
|
31
|
30
|
32
|
31
|
30
|
52
|
42
|
34
|
51
|
71
|
55
|
43
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
1
|
2
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
|
| Total Current Assets |
18
|
25
|
27
|
29
|
33
|
41
|
52
|
44
|
60
|
75
|
80
|
94
|
93
|
93
|
95
|
105
|
133
|
121
|
114
|
146
|
201
|
169
|
155
|
|
| PP&E Net |
6
|
8
|
9
|
9
|
11
|
12
|
15
|
16
|
17
|
17
|
18
|
18
|
18
|
19
|
21
|
19
|
22
|
23
|
29
|
28
|
29
|
39
|
39
|
|
| PP&E Gross |
6
|
8
|
9
|
9
|
11
|
12
|
15
|
16
|
17
|
17
|
18
|
18
|
18
|
19
|
21
|
19
|
22
|
23
|
29
|
28
|
29
|
39
|
39
|
|
| Accumulated Depreciation |
7
|
8
|
9
|
9
|
10
|
11
|
15
|
16
|
17
|
18
|
20
|
21
|
23
|
24
|
26
|
25
|
25
|
27
|
32
|
37
|
30
|
33
|
35
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
|
| Goodwill |
0
|
1
|
3
|
3
|
3
|
4
|
9
|
9
|
12
|
15
|
16
|
17
|
17
|
18
|
18
|
14
|
15
|
15
|
14
|
14
|
16
|
16
|
16
|
|
| Long-Term Investments |
1
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
4
|
6
|
6
|
6
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
1
|
3
|
3
|
3
|
4
|
9
|
9
|
12
|
15
|
16
|
17
|
17
|
18
|
18
|
14
|
15
|
15
|
14
|
14
|
16
|
16
|
16
|
|
| Total Assets |
24
N/A
|
35
+45%
|
40
+13%
|
43
+8%
|
50
+16%
|
60
+20%
|
78
+31%
|
71
-9%
|
91
+28%
|
110
+21%
|
117
+6%
|
132
+13%
|
132
0%
|
137
+4%
|
139
+2%
|
144
+3%
|
175
+22%
|
165
-6%
|
163
-1%
|
194
+19%
|
257
+32%
|
234
-9%
|
221
-6%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
9
|
14
|
13
|
15
|
16
|
21
|
25
|
21
|
31
|
40
|
37
|
42
|
42
|
39
|
40
|
49
|
69
|
58
|
46
|
69
|
86
|
145
|
56
|
|
| Accrued Liabilities |
0
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
5
|
5
|
5
|
4
|
4
|
4
|
3
|
3
|
4
|
3
|
5
|
6
|
11
|
5
|
3
|
|
| Short-Term Debt |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
3
|
4
|
4
|
3
|
3
|
4
|
10
|
4
|
3
|
3
|
2
|
2
|
3
|
3
|
4
|
4
|
6
|
6
|
7
|
|
| Other Current Liabilities |
2
|
2
|
2
|
2
|
2
|
2
|
4
|
2
|
2
|
5
|
3
|
4
|
2
|
3
|
3
|
2
|
3
|
2
|
2
|
3
|
10
|
2
|
3
|
|
| Total Current Liabilities |
11
|
18
|
18
|
19
|
22
|
28
|
36
|
28
|
42
|
55
|
56
|
55
|
52
|
49
|
48
|
56
|
80
|
67
|
58
|
82
|
113
|
83
|
69
|
|
| Long-Term Debt |
1
|
1
|
0
|
0
|
2
|
3
|
5
|
3
|
2
|
3
|
4
|
4
|
2
|
4
|
3
|
2
|
4
|
3
|
7
|
6
|
11
|
14
|
14
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
12
N/A
|
19
+62%
|
19
-3%
|
20
+8%
|
25
+25%
|
32
+26%
|
42
+33%
|
32
-24%
|
44
+37%
|
59
+34%
|
60
+2%
|
61
+1%
|
55
-10%
|
54
-2%
|
52
-3%
|
58
+12%
|
84
+44%
|
70
-16%
|
65
-7%
|
89
+36%
|
126
+42%
|
99
-21%
|
86
-13%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
|
| Retained Earnings |
9
|
13
|
17
|
16
|
15
|
17
|
20
|
23
|
26
|
30
|
35
|
40
|
45
|
50
|
53
|
51
|
56
|
60
|
63
|
69
|
83
|
86
|
85
|
|
| Additional Paid In Capital |
1
|
1
|
3
|
4
|
8
|
9
|
13
|
13
|
17
|
17
|
18
|
27
|
28
|
28
|
29
|
30
|
30
|
30
|
31
|
32
|
42
|
43
|
44
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
13
N/A
|
16
+28%
|
22
+34%
|
23
+7%
|
25
+10%
|
28
+12%
|
36
+28%
|
40
+9%
|
47
+20%
|
52
+9%
|
57
+10%
|
72
+26%
|
77
+8%
|
83
+7%
|
87
+5%
|
85
-2%
|
91
+7%
|
95
+4%
|
98
+3%
|
106
+8%
|
131
+24%
|
135
+3%
|
135
0%
|
|
| Total Liabilities & Equity |
24
N/A
|
35
+45%
|
40
+13%
|
43
+8%
|
50
+16%
|
60
+20%
|
78
+31%
|
71
-9%
|
91
+28%
|
110
+21%
|
117
+6%
|
132
+13%
|
132
0%
|
137
+4%
|
139
+2%
|
144
+3%
|
175
+22%
|
165
-6%
|
163
-1%
|
194
+19%
|
257
+32%
|
234
-9%
|
221
-6%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
30
|
31
|
9
|
10
|
12
|
13
|
14
|
15
|
17
|
17
|
17
|
19
|
19
|
19
|
19
|
20
|
20
|
20
|
20
|
20
|
22
|
23
|
23
|
|